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Abstract: 
The SHIP1 gene is a member of the inositol polyphosphate-5-phosphate (INPP5) 
and its expressed protein functions as a negative regulator of myeloid cell proliferation, 
survival, and migration. Mutations in this gene are associated with various defects and 
cancers of the immune system.  Previous studies have shown that in response to wound 
formation, ship1-deficient zebrafish have increased neutrophil motility while 
overexpression of ship1 resulted in decreased neutrophil migration (Lam et al. 2012).  
From this research, it is suggested that SHIP1 is a key brake that limits neutrophil 
motility through a PI3K signaling-dependent pathway.  While the role of SHIP1 during a 
wound response has been categorized, its function during a viral infection has been left 
uncharacterized.  The goal of this present study is to examine the role of ship1 during an 
innate immune response to an influenza infection. 
Using the zebrafish, Danio rerio, as an in vivo model organism, we hope to reveal 
the role of SHIP1 in the innate immune response to a viral infection.  It was initially 
discovered that upon viral infection, SHIP1 is upregulated, promoting further research 
into the role of SHIP1 in the antiviral innate immune response. Morpholino-mediated 
SHIP1 knockdown resulted in increased zebrafish survival upon influenza infection, 
suggesting that SHIP1 is a critical part of the antiviral immune response. Furthermore, 
SHIP1-KD in zebrafish exhibited decreased production of ROS, indicating that SHIP1 
plays a role in pathogen killing. 
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INTRODUCTION 
In order for an organism to defend itself from invading pathogens, the two components of 
the immune system: the innate immune system and the adaptive immune system must 
both be functioning properly.  The innate immune system is the first line of defense and 
is present among all organisms, making it the subject of a wide range of research. The 
innate immune system is comprised of numerous cells including neutrophils and 
macrophages, involved in the phagocytosis and eradication of foreign organisms.  
Important steps in microbial killing are migration and phagocytosis, which in neutrophils, 
is tightly regulated by the phosphoinositide 3-kinase (PI3K) pathway and the control of 
the key signaling molecule, phosphatidylinositol (3,4,5) triphosphate (PIP3). 
Viruses are intracellular pathogens that utilize the host cell machinery to replicate viral 
particles to cause infection.  There are around 200 different viruses that are known to 
infect humans but despite their prevalence, vaccines are only available for 15 of the 
diseases caused by these viruses, necessitating the need for new antiviral treatments 
(Small and Ertl, 2011).   
Many viruses have managed to evade microbial killing by disrupting the innate immune 
system.  Recently, our lab has discovered that a key enzyme in neutrophil migration, 
phagocytosis, and microbial killing, SHIP1, is upregulated during a viral infection.  
SHIP1 degrades the key signaling molecule, PIP3, to phosphatidylinositol (3,4) 
diphosphate (PIP2) in the PI3K pathway, which inhibits important cell functions such as 
cell motility, protein synthesis, and actin polymerization.  Further research into the role of 
SHIP1 during a viral infection could aid in the development of new and effective antiviral 
treatments.  
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BACKGROUND 
Those who are infected with influenza, also known as the flu, experience the symptoms 
of fever, cough, congestion, aches, and fatigue.  These symptoms are a result of a 
systemic viral infection which is acquired primarily through inhalation of airborne 
droplets from another infected individual.   
Viral infections are common in the human populations.  As obligate intracellular 
organisms, viruses are able to control and employ the host cell machinery to replicate and 
further cause infection. More than 90% of human illnesses may be caused by viral 
infections, which are generally systemic (Norkin et al., 2009).  To combat viral 
infections, organisms utilize both innate and adaptive immune responses.  The innate 
immune system is the first line of defense and is conserved among all organisms (Parkin, 
2001). A critical cell in the innate immune response is the neutrophil.  Neutrophils are 
phagocytic cells that migrate from the blood stream into infected tissues via chemotaxis.  
Once inside tissues, neutrophils are able to recognize foreign material through pathogen 
recognition receptors (PRRs) and the binding of pathogen associated molecular patterns 
(PAMPs)(Akira et al. 2006).  Upon recognition of viral material, neutrophils are able to 
phagocytose and kill the invading pathogen via both oxygen dependent and independent 
mechanisms.  A key cellular pathway in cellular motility, phagocytosis, and microbial 
killing is the phosphoinositide 3-kinase (PI3K) pathway. The key signaling molecule 
generated by this pathway, phosphatidylinositol (3,4,5) triphosphate (PIP3), mediates 
myriad cellular functions including protein synthesis, glucose metabolism, and actin 
polymerization at the cell surface.  The phosphatase, SHIP1 has been characterized as an 
essential negative regulator of PIP3, inhibiting an overactive immune response and, 
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preventing damage (Lam et al., 2012).  In zebrafish, it has been revealed that upon an 
influenza infection, SHIP1 is positively regulated, raising questions regarding the 
influence that the virus has on the host’s machinery. 
Due to issues accompanying the use of a variety of conventional animal models, and the 
clear ethical concerns surrounding human testing, zebrafish are commonly employed as 
models for human disease.  Zebrafish are an established instrument for research into 
development, genetics, cancer, immunity, and infection.  Advantages of the zebrafish 
versus its counterparts, the mouse (Mus musculus) and the fruit fly (Drosophila 
melanogaster), are its short generation time, optical clarity, and its cellular and molecular 
similarity to humans (Lieschke and Currie, 2007).  The zebrafish genome is fully 
sequenced and demonstrates high conservation between the human genome, making it a 
useful model for human immunity and disease.   
Previous studies have shown that the knockdown of the SHIP1 gene leads to increased 
neutrophil migration, while overexpression of SHIP1 saw decreased neutrophil motility 
(Lam et al.,2012).  Viral infection led to an initial upregulation of SHIP1 in these studies. 
SHIP1 may play an important role in neutrophil activity, specifically upon a viral 
infection. Understanding the mechanisms behind neutrophil activity, particularly the role 
of SHIP1, will aid in developing new and effective antiviral treatments.  
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VIRUSES 
Viruses are categorized as intracellular pathogens that are composed of proteins and 
genetic information in 
the form of either DNA 
or RNA encompassed in 
a capsid.  In order for 
the virus to replicate its 
genetic information and 
increase its 
pathogenicity, it must 
utilize host cell 
enzymes and other 
machinery (Garcia-
Sastre and Biron, 2006).  
When a virus comes 
into contact with a host 
cell, it can insert its genetic information into the cell and then manipulate the host cell 
machinery to replicate its genome and viral proteins.  Upon accumulation of viral 
proteins, the virus exits the cell to infect other cells, usually resulting in the death of the 
host cell (Garcia-Sastre and Biron, 2006). 
Viruses are prevalent throughout the world and are responsible for countless infections 
and diseases (FIG.1). Over time, viruses have developed processes to evade the host 
cells’ immune system, further increasing their pathogenicity.  Understanding the 
	  
Fig. 1 Overview of viral infections in humans (Harvey et al., 2007) 
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processes by which viruses are able to evade the immune system will provide insights 
into diagnosis, treatment, and elimination of viral diseases. 
INFLUENZA VIRUS 
Influenza, commonly known as the seasonal flu, is a virus that can infect many types of 
animals including birds, horses, pigs, and humans and is characterized by seasonal 
epidemics and pandemics (Schaechter et al 2013).  In the United States, influenza ranks 
among the major public 
health threats, causing an 
annual average of about 20 
million respiratory illnesses, 
100,000 hospitalizations, and 
more than 20,000 deaths 
(Schaechter et al 2013).  
Influenza type A and B are 
responsible for most 
infections in humans. 
Influenza enters the host 
through inhaled airborne respiratory droplets that then infect the upper and lower 
respiratory tract.  Symptoms of an influenza virus are fever, headache, and overall 
fatigue. 
All influenza viruses contain eight negative sense, single stranded RNA segments 
surrounded by the matrix (M) protein (Fig 2).  Each RNA segment is encapsulated by the 
viral nucleoprotein (NP) and the three virus-encoded polymerase proteins (PA, PB1, and 
	  
Fig. 2 Structure of the influenza virus (Clancy. 2008) 
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PB2) (Schaechter et al 2013).  The matrix protein is surrounded by a host-derived lipid 
bilayer membrane with surface glycoproteins.  The two glycoproteins, neuraminidase 
(NA) and hemagglutinin (HA), undergo antigenic drift or antigenic shift resulting, in 
changes in their composition.  These changes allow the virus to evade the immune system 
and persist in the respiratory tract.  Influenza infection of cells begins with the binding of 
HA to the sialic acid-containing glycolipid or glycoprotein viral receptors on the cell 
surface.  Upon attachment, the cell then engulfs the virus through an endocytic vesicle 
(Schaechter et al 2013).  The virus is then uncoated and its RNA segments are released 
into the cytoplasm.  The RNA enters the nucleus where mRNA is replicated, resulting in 
the formation of new viral particles. The viral particles then exit the cell through lysis to 
further infect other cells. This present study employs influenza as a model virus to 
examine the immune system in these zebrafish. 
ZEBRAFISH AS A MODEL ORGANISM 
Due to ethical issues surrounding the use of biological testing on humans, animals have 
been employed to research infectious diseases in the human. In vivo animal testing is 
preferred over in vitro testing involving cell or tissue culture, as animals are complete 
biological systems and their use can provide insight into the complex cellular 
interactions, three-dimensional cellular geometry, and homeostatic regulation. 
Biomedical research depends on the use of animal models to study to the pathologies of 
human diseases at the cellular and molecular level (Lieschke and Currie 2007).  
Mammals, such as the mouse (Mus musculus), have been successful models for human 
disease as they have close genomic similarity as well as anatomy, cell biology and 
physiology.  However, due to financial and physical restrictions on the use of mammalian 
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models, invertebrate models have been preferred for genetic studies (Fig.3).  Despite 
their advantages, invertebrates lack organ systems similar to those that are involved in 
human disease pathogenesis, thereby limiting their use in viral infection studies.  This is 
where the use of zebrafish 
(Danio rerio), has come 
into play.   
Since 1930, zebrafish have 
been employed as an 
embryological and 
developmental model 
(Lieschke and Currie 
2007).  In the 1980s and 
1990s, the development of 
genetic techniques such as 
cloning, mutagenesis, 
transgenesis, and mapping 
approaches established the 
zebrafish as a standard for 
developmental biology 
research. Zebrafish are vertebrate organisms that share striking anatomical and 
physiological homologies with higher organism counterparts, while maintaining the 
advantages of a lower organism (Goldsmith and Jobin 2012). Zebrafish have many 
characteristics that make them useful for studying human pathologies. They are highly 
	  
Fig 3. While there are many advantages and disadvantages 
to employing various model organisms for human diseases, 
the zebrafish has been established as an excellent model 
organism for human diseases (Liescke and Currie, 2007) 
8 
	  
fecund with over 100 embryos per clutch, larvae that are functional for experiments 3 
days after fertilization. Zebrafish are transparent up to 7 days after fertilization. They can 
also be genetically manipulated, contain a genome that is fully mapped, and possess 
organ and genetic homology to humans.  Additional benefits include: external 
fertilization (allowing access to the various developmental stages), short generation time 
(3-4 months), egg size (0.7mm in diameter), and their short developmental period, i.e., all 
major organs are developed within 36 hours of fertilization (Spence et al. 2008) (Fig 4). 
Zebrafish possess an 
innate immune system 
comprised of neutrophils, 
NK cells, and 
monocyte/macrophage that 
are functional at 48 hours 
post fertilization 
(Goldsmith and Jobin 
2012). The innate immune system is functional at 2 days post fertilization, while the 
adaptive immune system does not become fully functional until 4-6 weeks post 
fertilization.  This time difference allows for studies that involve the innate immune 
system specifically.  The adaptive immune system is highly analogous to that of 
mammals, containing T cells and B cells, as well as a nearly complete set of Toll-Like 
Receptors (TLRs) and associated innate signaling proteins, such as myeloid 
differentiation primary response 88 (MyD88) and nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-κB) (Goldsmith and Jobin, 2012). Studies using 
fFIgd
	  
Fig	  4. Image of the anatomy of the zebrafish taken using 
brightfield microscopy 6 days post fertilization. Scale bar is 
1mm.  Benefits of using zebrafish are its small size and 
transparency. (Goldsmith and Jobin, 2012)	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zebrafish-human homolog genes of the immune system are made possible through the 
constant updating of an online database containing extensive genomic information 
(Goldsmith and Jobin, 2012).   
One of the most important qualities of the zebrafish for research is its transparency.  The 
optically clear embryos allow real time imaging of critical cellular processes such as 
phagocytosis and chemotaxis during an immune response.  Using transgenic strains of 
zebrafish that express fluorescently labeled immune cells or pathogens, in vivo imaging 
of the interactions between the host and the pathogen is possible (Meijer and Spaink, 
2011). 
Although using zebrafish as a model for human pathologies has many advantages, there 
are limitations to its uses.  Because the use of zebrafish is relatively new, there are fewer 
available strains compared to with the mouse model.  Zebrafish also have numerous 
duplicate genes, which complicates forward-reverse genetic manipulation (Goldsmith and 
Jobin, 2012).  The environmental conditions for maintaining zebrafish differ significantly 
from those of humans.  Zebrafish also require 28°C water containing specific ion 
concentrations.  These requirements present certain limitations to the use of zebrafish for 
providing a complete representation of human biological processes. 
To date, zebrafish have played a critical role in biomedical research.  Zebrafish have been 
shown to be susceptible to bacterial, protozoan, and viral infections, which is important 
for modeling human diseases (Goldsmith and Jobin, 2012).  At the University of Maine, 
it has been shown that zebrafish can be infected with the gram negative bacterium, 
Pseudomonas aeruginosa in Dr. Carol Kim’s Lab, the fungus Candida albicans in Dr. 
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Robert Wheeler’s Lab, and also the virus, Influenza also in Dr. Carol Kim’s Lab.  These 
discoveries provide the foundation for further biomedical research on human pathologies. 
IMMUNITY 
As stated earlier, zebrafish exhibit an immune system that is similar to that of humans.  
Both branches of immunity, innate and adaptive, are present in the zebrafish, which 
allows it serve as a model for human disease.  More importantly, the adaptive immune 
system is not developed until 4-6 weeks post fertilization, allowing studies that are 
specific to the innate immune system (Goldsmith and Jobin, 2012). 
The immune system is divided into 2 broad components: innate immunity and adaptive 
immunity (Fig 5).  In order for an organism to successfully recognize and eliminate a 
pathogen, the two components must function properly.  In order to function efficiently, 
the host’s immune system must fulfill three requirements: (1) recognize a wide, but 
	  
Fig 5. Host immunity is composed of two components: innate immunity and adaptive immunity.  
The innate immune response is first line of defense against infection, while adaptive immunity 
provides a highly specific response, but takes longer to activate (Townsend et al., 2008). 
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diverse array of pathogens, (2) rid the host of these pathogens once they are recognized 
by the immune system, and (3) differentiate between self and non-self (Beutler et al. 
2004).  The interactive network responsible for facilitating the immune response is 
comprised of lymphoid organs, cells, humoral factors, and cytokines.  Improper 
functioning of these components can result in an underactive or overactive immune 
system, resulting in immunodeficiency, autoimmunity, or allergies (Parkin 2001). 
The innate immune system is the host’s first line of defense against infections. It reacts 
immediately to infection, with a comprehensive, broad range response that targets most 
pathogens. There are physical and chemical barriers, such as the skin and mucous 
membranes, and cellular components such as neutrophils, macrophages and natural killer 
(NK) cells.   The interaction of these mechanisms in the body with the invading microbes 
often leads to a constellation of responses called inflammation (Schaechter et al. 2013).  
The innate immune response is present among all metazoan, plant, invertebrate, and 
vertebrate organisms.  Vertebrate animals, such as humans and zebrafish, developed a 
second line of defense called adaptive immunity. 
While the innate immune system employs genetically encoded receptors that detect and 
recognize foreign materials, the adaptive immune system uses a different subset of 
leukocytes called lymphocytes.  This elite set of leukocytes known as B-cells and T-cells 
have the capacity to generate a large number of antigen-specific cell surface receptors by 
random rearrangement (Schaechter et al. 2013).  Despite taking days or weeks to develop, 
the adaptive immune system is able to clear the pathogen as well as generate 
immunologic memory.  Creating immunologic memory allows the host immune system 
to elicit a rapid and specialized response when encountering the same pathogen in the 
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future (Bonilla and Oettgen, 2009). Although the adaptive immune response is more 
effective at eliminating specific pathogens, its activation requires signaling from the 
innate immune system. 
The immune system is able to discriminate between foreign pathogens and harmless 
microbes through the use of pattern recognition receptors (PRRs). One family of PRRs is 
called toll-like receptors (TLRs).  TLRs recognize many essential microbial molecules, 
including essential cellular components such as lipopolysaccharide, lipoproteins, 
lipoteichoic, peptidoglycan, flagella, bacterial DNA, fungal cell walls, and viral RNA 
(Schaechter et al. 2013). For example, in the case of an influenza infection, TLR7 and 
TLR8 recognize single stranded viral RNA, activating viral inhibitory proteins, MyD88 
and NF-κB, as well as interferons to activate macrophages and NK cells. 
Of all the innate antimicrobial defenses in the body, the most potent is the cellular 
response which consists of neutrophils, eosinophils, and monocytes into infected tissues 
(Schaechter et al. 2013).  Neutrophils are phagocytic cells that are recruited to the site of 
infection and are crucial for a proper immune response. In order for neutrophils to be 
effective, they must first migrate to the site of infection.  Infected or damaged tissues and 
other immune cells elicit cytokines that attract neutrophils.  Cytokines are small secreted 
proteins that play a crucial role in the interaction and communication between cells.  Cell 
surface receptors on neutrophils allow for the detection of chemical gradients from 
cytokines guiding them to the site of infection via chemotaxis. 
Once neutrophils have migrated from the blood stream into tissues they recognize foreign 
pathogens through surface receptors such as TLRs, C-type lectin receptors, and 
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nucleotide-binding oligomerization protein 1 (NOD1) (Mantovani et al. 2011).  Early 
signaling events, such as the phosphorylation of phosphatidylinositol 4,5-bisphosphate 
(PIP2) to phosphatidylinositol 3,4,5-trisphosphate (PIP3) through the PI3K pathway 
induce polymerization of actin and remodeling of the localized membrane, which is 
essential for particle ingestion (Lee et al. 2003).  After engulfing the pathogen, the 
neutrophil develops machinery that is necessary to kill it.  To eradicate the pathogen, the 
neutrophil employs contents of intracellular granules.  The largest of these, the 
azurophilic granules contain various antimicrobial substances to kill invading pathogens. 
Azurophil-type granules contain peptides such as α-defensin and phospholipase A2, and 
enzymes such as lysozyme, elastase, and myeloperoxidase enzymes, which produce 
hypochlorous acid (HOCl) and Cl- to kill the pathogen. Specific-type granules contain 
peptides such as cathelicidin and lactoferrin, and enzymes such as lysozyme and NADPH 
oxidase, which are used to eradicate the pathogen (Schaechter et al. 2013).  Once the 
microbe is killed, the phagolysosomes accumulate in the cytoplasm and the neutrophil 
eventually lyses and the resulting debris are phagocytosed by macrophages. 
Neutrophils play a critical role in the immune response. It has been demonstrated that 
neutrophils also act as an important bridge between the innate and adaptive immune 
response as they are important mediators of T helper cells and activators of B cells 
(Mantovani et al. 2011).   Organisms that suffer from congenital or acquired defects in 
neutrophil life cycle and function can experience chronic infections and other life 
threatening conditions, demonstrating the importance of the neutrophil in the immune 
response. 
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PI3K SIGNALING PATHWAY 
Neutrophils are vital to an effective immune response.  Upon exposure to inflammatory 
signals neutrophils perform several specialized functions including chemotaxis, 
phagocytosis, and microbial killing (Moraes and Downey, 2003).  In order to be 
successful in eradicating invading pathogens neutrophils rely on the 
phosphatidylinositide 3-kinase (PI3K) pathway.  Phosphatidylinositide 3-kinases are a 
group of enzymes that convert plasma membrane phosphatidylinositol-4,5-biphosphate 
(PIP2), to phosphatidylinositol-3,4,5-trisphosphate (PIP3) upon exposure to signals in the 
form of growth factors, chemokines, and cytokines on the cell surface.  PIP3 is the key 
messenger in the PI3K signaling pathway.  Formation of PIP3 initiates numerous cellular 
functions such as phagocytosis, chemotaxis, microbial killing, and apoptosis through 
activation of numerous other pathways (FIG 6).  If the PI3K pathway is overactive, 
resulting in the overproduction of PIP3, immune cells can produce a detrimental immune 
response which leads to excessive inflammation and damage of tissues.  To control the 
level of PIP3, phosphatases PTEN and SHIP1 degrade PIP3 to its inactive form, PIP2. It 
is well established that in neutrophils, chemoattractant signaling via G protein-coupled 
receptors induces an increase in the PIP3/PIP2 ratio at the leading edge during 
chemotaxis in vivo (Yoo et al., 2010).  Activation of PI3K results in rapid polarized F-
actin polymerization, which is crucial for cellular motility (Barberis and Hirsch, 2008). 
Without the key PIP3 molecule, immune cells cannot migrate to the site of infection and 
perform specialized functions such as phagocytosis, microbial killing, and apoptosis 
(Moraes and Downey, 2003). 
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The PI3K family of enzymes is divided into 3 classes, I, II and III, according to their 
primary structure and substrate specificity (Moraes and Downey, 2003).  Class II and III 
kinases are expressed 
in all cells, but their 
mechanisms of action 
are not well 
understood.  Class I 
kinases are further 
divided into two 
subgroups, IA and IB.  
The catalytic subunit, 
p110 has four 
recognized isoforms: 
p110-α, β, δ, in class IA and γ in class IB.  Class IA p110 subunits are activated 
predominantly by receptor tyrosine kinases (RTK).  P110α and β are ubiquitously 
expressed in tissues while p110δ and γ of class IB are primarily found in leukocytes 
(Moraes and Downey, 2003).  
The PI3K pathway is initiated by the activation of the PI3-kinase enzymes. Through 
receptor tyrosine kinases (RTKs), integrins, B and T cell receptors, cytokine receptors, G-
protein-coupled receptors and many others.  Binding of extracellular growth factors to 
plasma membrane-bound RTK results in dimerization and autophosphorylation.  
Dimerization and autophosphorylization at the tyrosine residues allows the RTKs to 
interact with SH2 domain containing molecules, such as SHIP1 phosphatases (Castellano 
	  
Fig 6. Overview of the PI3K signaling pathway. The key signaling 
molecule PIP3 which is produced via this pathway mediates various 
cell functions such as protein synthesis, cell motility, and 
phagocytosis (Moraes and Downey, 2003). 
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and Downard, 2011).  Lipid kinase PI3K is then recruited to the plasma membrane 
binding site and PI3K is activated.  PI3K then converts membrane bound PIP2 to its 
active form, PIP3.  PIP3 drives various downstream pathways such as Akt, Rac, and Arf6 
to regulate numerous cellular functions such as cell migration, phagocytosis, cell survival 
and microbial killing.  These cytosolic proteins have pleckstrin homology (PH) domains 
that bind to PIP3, leading to their activation (Moraes and Downey, 2003).  Numerous 
studies have shown that in neutrophils, the PI3K pathway plays a central role in 
endothelial adhesion and transmigration into infected tissues, chemotaxis, phagocytosis, 
microbial killing, and apoptosis (Moraes and Downey, 2003). 
AKT/PKB PATHWAY 
The serine/threonine kinase, Akt/PKB, and its isoforms consist of a conserved domain 
structure: an amino terminal pleckstrin homology (PH) domain, a central kinase domain, 
and a carboxyl-terminal regulatory domain (Song et al. 2005).  The PH domain of the 
protein kinases interacts with PIP3 that is produced by PI3-kinase. All Akt isoforms have 
two regulatory phosphorylation sites, Thr308 in the activation loop within the kinase 
domain and Ser473 in the C-terminal regulatory domain.  Activation of Akt requires a 
PI3-kinase and a PH domain translocation, as well as phosphorylation of both sites (Song 
et al. 2005).  While phosphorylation of the Thr308 site partially activates Akt/PKB, full 
activation requires phosphorylation of both sites.  The PH domain is required for the 
recruitment of Akt/PKB to the plasma membrane through the high affinity binding to 
PIP3 (Song et al. 2005).  PIP3 does not activate Akt/PKB, but instead recruits it to the 
plasma membrane to be phosphorylated by the phospho-inositide-dependent kinase-1 
(PDK1).  Once at the plasma membrane, Akt/PKB is phosphorylated at two specific sites, 
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Thr308 and Ser473.  Thr308 is the main site for phosphorylation, which is accomplished 
by PKB.  Less is known about the phosphorylation of Ser473 but there is evidence 
suggesting that it can be auto phosphorylated or phosphorylated by the integrin-linked 
kinase (Song et al. 2005).  The phosphorylated Akt/PKB can then go on to activate 
transcription factors, proteins and other signaling pathways that control apoptosis, cell 
growth, and glucose metabolism. 
RAC PATHWAY 
Other PH domain-containing 
proteins that are activated by PIP3 
include guanosine diphosphate 
(GDP)-GTP exchange factors for 
Rac proteins (Cantley et al. 2002).  
Rac proteins are a subfamily of the 
Rho family of monomeric GTPases 
and are responsible for multiple 
cellular functions such as cell 
adhesion, transcriptional and 
translational activation, protein 
synthesis, as well as formation of 
reactive oxygen species by NADPH oxidase complex in neutrophils which is crucial for 
microbial killing (Welch et al. 2003).  Rac proteins are molecular switches that are 
inactive when GDP is bound and active when bound to GTP (Fig 7).  Rac-GDP 
complexes are attached to the membrane through its C-terminal prenylation, exposing 
	  
Fig 7. The Rac pathway is activated by PIP3 via 
their PH domain-containing proteins.  Once 
activated, Rac GTPases are responsible for cell 
adhesion, protein synthesis and other cell functions 
(Cantley et al., 2002). 
18 
	  
them to the activating enzyme, a guanine-nucleotide exchange factor, GEF (Welch et al. 
2003).  GEF is able to expose the nucleotide binding site of the GTPase, which facilitates 
the dissociation of GDP and binding of GTP, which is present at high concentrations in 
the cytosol of the cell.  Rac activation can be accomplished in both PI3K-dependent and 
PI3K-independent pathways through the activation of GEF, but a large number of Rac-
GEF families can be activated directly by PIP3.  Once Rac proteins are activated, they 
can bind to their target proteins which are crucial to myriad functions in the cell. 
ARF6 PATHWAY 
The ADP-ribosylation factors (Arfs) 
belong to a family of Ras-related 
GTP-binding proteins.  Much like 
Rac proteins, Arfs alternate between 
the inactive GDP-bound complex and 
the active, GTP-bound complex.  
Arf6 has been the subject of recent 
studies because of its effects on 
membrane trafficking and actin 
cytoskeleton at the plasma membrane 
(Donaldson, 2003).  Arf6 activation is 
facilitated by guanine nucleotide exchange factors (GEFs), which allows the binding of 
GTP.  While it is well understood that Arf6 plays a significant role in  control of the actin 
cytoskeleton to affect the cell shape, it also is required for cell migration (Fig 8).  Arf6 
has been recently shown to be crucial in leukocyte chemokine-stimulated migration 
	  
Fig 8. Arf6 are activated by PIP3 through their 
PH domain. Activation of Arf proteins results in 
the remodeling of cytoskeleton actin, changing 
cell shape (Donaldson, 2003). 
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Fig 9. This is the SHIP1 gene containing SH2 domain, the two 
NPXY domains, and the multiple PxxP binding domains 
(Rohrschneider et al. 2000). 
across epithelial cells (Donaldson, 2003). Actin cytoskeleton restructuring and cellular 
migration are key components to an effective immune response. 
SHIP1 
The SHIP1 phosphatase enzyme serves as a negative regulator of the key signaling 
molecule, phosphatidylinositol (3,4,5) triphosophate. SHIP enzymes contain 1190 amino 
acids, have a molecular mass of 133kD, and contain several motifs that are important for 
protein-protein 
interactions 
(Rohrschneider et 
al. 2000).  The 
central amino acid 
domain contains genetic information for the enzymatic activity of the SHIP enzyme, 
while the carboxy-terminal domain encodes two NPXY motifs and multiple PxxP motifs, 
and the SH2 domain is found at the N-terminus (Fig 9). Upon tyrosine phosphorylation 
of NPXY motifs, proteins with a phosphotyrosine binding (PTB) domain, like the tensin 
proteins, are able to interact with SHIP at these sites. Phosphorylation of the NPXY 
motifs also provides potential interaction sites for SH2 domain-containing proteins 
(Rohrschneider et al. 2000).  Several PxxP motifs are present on the carboxyl terminus 
and can serve as binding sites for proteins containing SH3 domains.  Together, these 
structural features comprise a unique and important protein that has enzymatic and 
signaling properties.  SHIP is expressed in almost all cells of the bone marrow and blood 
cells express at least one form of the SHIP protein (Rohrschneider et al. 2000).  SHIP 
mRNA has been found at the earliest stages of hematopoietic cell development in mouse 
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embryos and protein expression has been detected in all blood cell lineages including 
macrophages and granulocytes. SHIP homologues, SHIP1 and SHIP2 are expressed in all 
mammals, with SHIP1 expression limited to the hematopoietic lineage and while SHIP2 
is expressed broadly (Lam et al 2012).  Zebrafish express one copy of SHIP1 and two 
copies of SHIP2: SHIP2a and SHIP2b.  The central enzymatic domain of SHIP proteins 
has been identified by its similarity to inositol phosphates.  This domain is highly 
conserved (96% identical) between murine and human SHIP proteins.  SHIP enzymes 
remove the phosphate group from the 5’ position on both phosphatidylinositol 3,4,5 –
triphosphate [PI(3,4,5)P3] and 1,3,4,5-tetrakisphosphates (IP4) (Rohrschneider et al. 
2000).  The 3’ position of the inositol phospholipid must be phosphorylated before SHIP1 
can act on it, suggesting that SHIP acts sequentially with phosphatidylinositol 3 kinases 
(PI3K).  PI3K, which contains a 85-kD regulatory subunit and a 110-kD catalytic subunit, 
is responsible for PIP3 production. The p85 subunit of PI3K contains two SH2 domains, 
which are 
recognized by 
the p85 SH-2 
domain in SHIP 
proteins.  This 
p85/PI3K 
association with 
SHIP could 
represent an interesting complex of enzymes that convert PI(4,5)P2 to the key signaling 
molecule, PI(3,4,5)P3, then finally to PI(3,4)P2.  The PI(3,4)P2/ PI(3,4,5)P3 
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accumulation at the leading edge of neutrophils in vitro inspired research into the role of 
SHIP phosphatases during neutrophil motility in vivo. This work showed that in 
zebrafish, both SHIP1 and SHIP2 promptly localize to the leading edge and occasionally 
the tail of migrating neutrophils.  Deletion of SHIP1 increased neutrophil migration while 
overexpression inhibited neutrophil motility (Lam et al. 2012).  Since PI3K activity and 
leading edge PI(3,4,5)P3 is required for neutrophil motility in vivo (Yoo et al. 2010), it is 
suggested that SHIP1 hydrolyzes the key signaling molecule PI(3,4,5)P3 into PI(3,4)P2 
in neutrophils, thereby limiting their motility.  It has also been suggested that SHIP1 acts 
as a key brake in neutrophil migration to prevent a damaging, over active immune 
response via a PI3K signaling pathway. 
MORPHOLINO OLIGONUCEOTIDES (MO) 
Gene manipulation has long been a tool used in genetic research and developmental 
biology. Forward genetics focuses on the study of a specific phenotype and determination 
of the genetic basis for that phenotype (Lieschke and Currie, 2007).  Reverse genetics 
allows for the study of the biological function of a gene by altering the expression of that 
gene during development and observing the effects. 
The most widely used reverse genetics antisense technique in zebrafish involves 
morpholino oligonucleotides (MO), which are employed for gene knockdown.  MOs are 
synthetic oligonucleotides composed of 25 morpholine bases [O(CH2CH2)2NH] bound by 
a neutrally charged phosphorodiamidate backbone (Bill et al, 2009).  Although similar in 
structure to DNA and RNA oligomers, MO oligomers are neutrally charged; making 
them more stable in the cellular environment and the altered backbone allows them to 
resist degradation by circulating endogenous endonucleases.  Most importantly, the 
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morpholine bases can still participate in Watson-Crick base pairing allowing MOs to bind 
to specific cellular RNA sequences (Ekker and Akimenko, 2010).  Developed by Dr. 
James Summerton, MOs were first designed to inhibit translation of mRNA in vivo. 
There are two types of MOs: splice blocking and translational blocking morpholinos (Fig 
11).  Splice 
blocking MOs 
inhibit the function 
of the spliceosome, 
a protein complex 
that removes 
introns from pre-
mRNA (Bill et al, 
2009). 
Translational 
blocking MOs bind 
to complementary 
mRNA sequences 
within the 5’ 
untranslated region 
(UTR) which 
inhibits ribosome assembly, hence obstructing translation.  Procedures such as reverse 
transcription polymerase chain reaction (RT-PCR) can quantify the efficacy of a splice 
blocking MO, whereas a western blot assay can measure the efficacy of translation 
Fig 11. Gene knockdown technique employing MOs. (A) Structure of 
MOs, which is similar to DNA and RNA oligomers. (B,C,D) Splice 
blocking MO technique and (E,F) shows translational blocking MO 
mechanism (Bill et al., 2009). 
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blocking MOs.  Typically, MOs are introduced into zebrafish embryos at the 1-8-cell-
stage, allowing rapid, comprehensive delivery through the early embryonic cells (Bill et 
al, 2009).   
Although the use of MOs is beneficial for genetic research, it is a relatively new practice 
and certain constraints should be recognized.  First, in smaller embryos the repeated 
injection of specific volumes of MOs can be a source of error.  Inconsistent MO 
administration among embryos can result in unreliable gene expression (Eisen and Smith, 
2008).  Second, MO injection can affect off-target genes.  The MO can interfere with 
production of irrelevant gene products, thereby introducing the possibility that the newly 
observed phenotype is not the result of the targeted gene knockdown.  The last concern is 
the administration of the control.  The most reliable control is to attempt to “rescue” the 
phenotype by introducing the gene product of interest in a form that is unaffected by the 
MO (Eisen and Smith, 2008). An effective rescue technique is to inject mRNA at the 1-
cell stage.  In the case of a translational blocking MO, removing the 5’ UTR of the 
mRNA or introducing silent mutations into the coding region should rescue the 
phenotype (Eisen and Smith, 2008).  With a splice-blocking MO, injecting mRNA can 
also have the ability to rescue the phenotype (Eisen and Smith, 2008).  The use of MO 
knockdowns and other genetic manipulation techniques have allowed research into gene 
identification, gene function, and the verification of specific mutant phenotypes (Bill et 
al., 2009). 
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MATERIALS AND METHODS  
Zebrafish Maintenance, Antisense Morpholino Injection, Viral Injection, and 
Mortality: 
Zebrafish Maintenance.  Zebrafish embryos were held in 75 mL of egg water (60 mg/L of 
Instant Ocean, Spectrum Brands, Madison, WI) at 28°C.  Once the embryos were injected 
with virus, zebrafish larvae were held at 33°C in the same egg water solution. 
Antisense Morpholino Injection. Zebrafish embryos were injected with an antisense 
morpholino oligonucleotide at the 1 cell stage (0.5 to 1 hours post fertilization).  One 
SHIP1 splice-blocking morpholino (SHIP1 MO) was injected at 250 µM per embryo in a 
3 nL injection.  The control MO was injected at the same concentration and volume.  The 
SHIP1 MO was designed using Gene Tools, LLC (Table 1). 
Morpholino Sequence (5’ – 3’) 
SHIP1 MO ATG ACT TAA GAC ATC TCA CCC 
ATG T 
Control CCT CTT ACC TCA GTT ACA ATT 
ATA A 
Table 1 The SHIP1 morpholino sequence, designed by Gene Tools (Philomath, OR), was 
injected at the 1 cell stage. 
Mopholino efficiency was tested using RT-PCR.  After MO was injected, 6 fish were 
isolated at 1, 2, and 3 days post fertilization (dpf) for each treatment (control and SHIP1-
KD). After injection of MO, the expression of SHIP1 was expected to be greatly reduced, 
or knock down (SHIP1-KD). RNA was extracted using the Trizol protocol (Ambion) and 
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cDNA was then synthesized using the iScript protocol.  For PCR, the PCR MasterMix 
was used with the 2x kit protocol (Promega #9P1M750) with the following primers: 
Primer Sequence (5’-3’) 
SHIP1 Forward GTC TCC TGG AGC TGG AAG 
ACT AAG 
SHIP1 Reverse GTC ATG TGG GAT TTG AGG 
GGC TGT G 
The products were then analyzed on a 1% agarose gel.  10µL of PCR product was then 
loaded with 2µL of 6x Orange G dye. 
 
Viral Injection.  For survival studies: at 48 hpf, embryos were dechorionated with forceps 
and anesthetized in tricaine.  Influenza A/PR/8/34 (H1N1, EID50 109.6) virus (Charles 
River, North Franklin, CT) was injected into the tail vein to elicit a systemic infection in 
both SHIP1 morphant and control embryos. Two, 2 nL injections were administered per 
	  
         [   Ladder ][        LANE 1       ][         LANE 2         ][        LANE 3      ][  Ladder  ] 
Fig 12 Agarose gel results demonstrate that the SHIP1 MO at the concentration that was used 
efficiently knocked SHIP1 down through 3dpf.  Shifted bands represent an exon skip caused 
by the MO interaction. Gel setup: 1dpf – 2dpf – 3dpf with ladder on each end. 
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embryo with 12,720 Embryo Infective Dose, EID50 per fish. This is amount of virus 
particles required to infect 50% of the zebrafish.  The virus injection contained 8 µL of 
virus stock, 0.5 µL of 5% phenol red, and 1.5 µL Hanks Balanced Salt Solution (HBSS).  
The control injection contained 9.5 µL HBSS and 0.5 µL of 5% phenol red solution.  
For qPCR (Injection performed by Denise Jurczyszak of the Kim Lab): Charles River 
Stock EID50 1010.3/mL, an influenza virus stock was used in this experiment.  2 nL were 
injected into the tail vein of the zebrafish (12,500 EID50/embryo) to elicit a systemic 
immune response. 
Mortality. Embryos injected with control or IAV were kept in 50 mL of egg water 
throughout the experiment.  At 8 hours post infection (hpi), deceased embryos were 
removed and surviving embryos were counted.  This represented the count at Day 0.  At 
this stage, all deceased embryos were attributed to incidental trauma from injection rather 
than from IAV.  In 24 hour intervals, surviving embryos were counted through 5 days 
and egg water was changed upon each counting.   
RNA Extraction, cDNA Synthesis, qPCR, and Respiratory Burst Assay: 
RNA Extraction. Embryos from SHIP1-morphant and control zebrafish were collected at 
12, 24, 48, 72, 96, and 120 hpi.  Five zebrafish were used per replicate and three 
replicates were done for each treatment at each time point.  RNA was extracted using the 
Trizol protocol (Ambion).  To quantify the RNA extracted, a NanoDrop 
spectrophotometer was used. 
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cDNA Synthesis. cDNA was synthesized from the extracted RNA from each treatment 
and time points, using the iScript cDNA synthesis kit (BioRad, Hercules, CA).  The 
samples were the diluted to 50 ng/µL with nuclease free water. 
qPCR.  For a total of 10 uL per qPCR reaction, each reaction contained 5uL of SoFast 
EvaGreen mastermix (BioRad, Hercules, CA) or Quanta Green FastMix (Quanta, 
Gaithersburg, MD) as the fluorescent dye, 0.2 µL of forward/reverse target gene primer 
(0.2 µM final concentration) and 2uL of cDNA (10 ng/µL final concentration).  2.8 µL of 
nuclease free water was also added to bring the volume up to 10 µL.  Quantification cycle 
(Cq) values were calculated using a CFX96 real-time detection system. Analysis of these 
Cq values was then completed in GraphPad Prism 6. 
Primer Sequence (5’-3’) 
SHIP1 Forward GGC ACT TGG AAC ATG GGA AA 
SHIP1 Reverse CCT CCT GTG TCC CGA TTA CG  
18s Forward TCG CTA GTT GGC ATC GTT TAT G 
18s Reverse CGG AGG TTC GAA GAC GAT CA 
Table 2 The SHIP1 forward/reverse primers were added during qPCR measurements.  
The 18s forward and reverse primers were used as the control. Primers were 
designed by Gene Tools (Philomath, OR). Primers are designed to bind to the 
SHIP1 DNA sequence during the annealing phase, resulting in amplification of 
the SHIP1 gene to determine its relative expression. 
Respiratory Burst Assay (RBA). Zebrafish embryos were injected with MO as previously 
described.  The RBA was the performed at 3 dpf as described in (Goody et al., 2013) - 
with the exception that the plate was not shaken immediately after adding phorbol 
myristate acetate (PMA), instead it was placed directly into a 28°C incubator. The PMA 
was added along with the fluorescent molecule, H2DCFDA, to the zebrafish. The PMA 
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involves the activation of protein kinase C (PKC) which induces a respiratory burst of 
phagocytes.  Upon respiratory burst, the reactive oxygen species (ROS) that are produced 
inside the phagocyte react with the fluorescent molecule H2DCFDA. This reaction 
oxidizes H2DCFDA, causing it to fluoresce. The intensity of the fluorescence correlates 
to the amount of ROS produced within the phagocyte.  
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RESULTS 
SHIP1 is upregulated upon infection by influenza A virus.  To test the expression of 
SHIP1 in zebrafish during a viral infection, both control and SHIP1-KD zebrafish were 
injected with either influenza A virus or HBSS control.  At various time points, RNA was 
extracted and then synthesized into cDNA.  Real time qPCR was used to measure the 
levels of SHIP1.  Upon infection, SHIP1 is upregulated within the first 24 hpi until 
120hpi.  Statistical significance was found at 24, 72, 96, and 120hpi (Fig 13).  SHIP1 is a 
negative regulator of neutrophil activity, thereby decreasing the immune response. qPCR 
data show that SHIP1 is upregulated during the time frame during which the immune 
response would be strongest, suggesting that the influenza virus is able to manipulate 
SHIP1 expression, allowing the virus to evade the immune response. 
	  
	  
 
 
 
 
 
 
 
 
Fig 13. Relative expression profiles of SHIP1 in zebrafish after IAV infection. At various time 
points it can be seen that SHIP1 is upregulated upon IAV infection.  Both graphs represent separate 
experiments and with one injection performed by Campbell Miller and the other performed by 
Denise Jurcyzsak, both of the Kim Lab. 
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SHIP1 plays a critital role in zebrafish survival during an IAV infection.  To 
determine whether SHIP1 has a role in the innate immune response to a viral infection, 
H1N1 IAV was injected into 48 hpf, SHIP1-KD zebrafish.  Every 24 hours, the number 
of surviving zebrafish was determined and the precent survival was calculated over the 
span of 5 days.  At this early stage in development, only the innate immune system is 
present in zebrafish larvae and is responsible for clearing the viral infection.  As 
anticipated, IAV infection in control zebrafish resulted in decreased percent survival.  In 
SHIP1-KD zebrafish, however, IAV infection resulted in greater percent survival, 
suggesting that SHIP1 plays a role in the zebrafish innate immune response (Fig 14).   
 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
 
	  
Fig 15. Percent survival curves of control and SHIP1-KD zebrafish that were injected with 
either HBSS control or IAV.  The graph demonstrates that compared to control zebrafish 
infected with IAV, SHIP1-KD zebrafish infected with IAV has a greater percent survival 
that is statistically significant. 
	  
Fig	  14.	  Percent survival curves of control and SHIP1-KD zebrafish that were injected with 
either HBSS control or IAV.  The graph demonstrates that compared to control zebrafish 
infected with IAV, SHIP1-KD zebrafish infected with IAV has a greater percent survival that is 
statistically significant. Ct indicates zebrafish injected with control MO, while KD indicates 
zebrafish injected with SHIP1 MO.  These fish were then infected with IAV or HBSS. 	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SHIP1 plays a role in reactive oxygen species (ROS) production. Having established 
that SHIP1 is upregulated during an IAV infection and plays a role in the zebrafish 
antiviral immune response, it was of interest to explore its function in phagocyte activity.  
A respiratory burst assay was performed to determine the role of SHIP1 in ROS 
production in phagocytic cells.  SHIP1-KD and control zebrafish at 3dpf, were loaded 
onto microplates and PMA was added to induce a respiratory burst.  It was determined 
that SHIP1-KD zebrafish produced fewer relative fluorescence units (RFU) compared to 
control fish, indicating fewer ROS species were produced (Fig 15).  This data 
demonstrates that SHIP1 plays a critical role in ROS production. 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
Fig 15. Respiratory burst assay (RBA) results of control and SHIP1-KD 
zebrafish.  Results of the RBA demonstrate fewer RFU in SHIP-KD zebrafish 
compared to controls, indicating that SHIP1 plays a role in ROS production 
and microbial killing. 
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DISCUSSION 
Viruses are common throughout the world and cause numerous diseases. We are 
interested in studying the innate immune system as it pertains to specific viral infections.  
Using zebrafish as model organisms, these studies provide insight into a variety of 
pathways and mechanisms that contribute to viral pathology.  Understanding these 
mechanisms can contribute to the development of treatments for viral infections among 
humans.  The gene SHIP1 has yet to be characterized specifically during a viral infection, 
yet its role in the innate immune system during a wound response has been researched 
widely.  In the current study, the role of SHIP1 during an innate immune response to an 
influenza virus infection was investigated in vivo using zebrafish. 
 Previous studies revealed that SHIP1 is upregulated during an influenza infection 
in zebrafish (Campbell Miller, unpublished results).  SHIP1 enzymes act as negative 
regulators of neutrophil motility, possibly to prevent damage from an overactive immune 
response.  More specifically, SHIP1 phosphatases degrade the key signaling molecule	  
phosphatidylinositol (3,4,5) triphosphate (PIP3) at the plasma membrane to 
phosphatidylinositol (3,4) diphosphate (PIP2) in the phosphoinositide 3-kinase (PI3K) 
pathway.  Neutrophils rely on the PI3K signaling pathway to induce chemotaxis, 
phagocytosis of pathogens, and microbial killing. These data suggest that the virus causes 
upregulation of SHIP1, allowing it to evade the host innate immune response. SHIP1 
expression during a viral infection was established and so further research was performed 
to identify other effects SHIP1 might have during the antiviral innate immune response.   
 First, the role of SHIP1 in overall zebrafish survival was examined during an 
influenza infection.  SHIP1 MO was administered to zebrafish embryos at the one cell 
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stage in order to knock down SHIP1 expression.  The SHIP1-KD zebrafish and control 
zebrafish were then injected in the tail vein with HBSS control solution or IAV 48hpf to 
result in a systemic infection.  As expected, the control zebrafish infected with IAV had a 
decreased percent survival (Fig 14).  However, SHIP1-KD zebrafish had an increased 
percent survival, similar to that of control zebrafish injected with HBSS control solution.  
These data support the notion that the expression of SHIP1 during a viral infection is 
possibly mediated by the virus rather than the host to evade the immune response and 
cause further damage.  Knock down of SHIP1 led to increased survival indicating that 
increased SHIP1 expression during a viral infection, which was established by previous 
qPCR data (Fig 13), leads to decreased survival among IAV infected zebrafish.   
 A respiratory burst assay (RBA) was then performed to determine the effect of 
SHIP1 on production of reactive oxygen species (ROS).  ROS are chemically reactive 
molecules which are present in phagocytes and are responsible for microbial killing.  
RBA results demonstrated that SHIP1-KD zebrafish exhibited less fluorescence (relative 
fluorescent units - RFU) compared to control zebrafish.  These data indicate that SHIP1-
KD zebrafish produced lower levels of ROS compared to control zebrafish.   These 
results suggest that SHIP1 plays a role in microbial killing through the production of 
ROS. Although upregulation of SHIP1results in higher levels of ROS, and subsequently 
more pathogen killing, this could have a damaging effect as well.  Elevated levels of 
ROS, and their release upon phagocyte apoptosis, can damage host epithelial cells.  
During a viral infection, the upregulation of SHIP1 causes an increase in the production 
of ROS which, could further damage the host and be, in part, responsible for the 
decreased percentages survival values (Fig 14).   
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 The data presented are consistent with the hypothesis that SHIP1 plays a critical 
role in the innate immune system during an influenza infection.  Although SHIP1 serves 
as a negative regulator of neutrophil motility to prevent an over active immune response, 
aberrant and increased expression of SHIP1 during an influenza infection, can lead to 
increased host damage, decreased survival, and decreased ROS production., Further 
research is needed to fully characterize the role of SHIP1in the innate immune response 
as this could lead to the development of antiviral treatments, especially those directed 
toward influenza infections.	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